← FDA Drug Approvals (Drugs@FDA)
ELOXATIN
NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 2002-08-09
Drug application
- FDA Application #
NDA021492- Application type
- New Drug Application
- Brand name
- ELOXATIN
- Generic name
- Oxaliplatin
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- SANOFI AVENTIS US
- First approval
- 2002-08-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown